Boston Scientific Corporation (BIT:1BSX)
Italy flag Italy · Delayed Price · Currency is EUR
62.00
+0.60 (0.98%)
At close: Mar 6, 2026

Boston Scientific Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
20,07416,74714,24012,68211,888
Revenue Growth (YoY)
19.87%17.61%12.29%6.68%19.92%
Cost of Revenue
6,2215,2574,3453,9563,711
Gross Profit
13,85411,4909,8968,7278,177
Selling, General & Admin
6,8875,9845,1904,5204,359
Depreciation & Amortization Expenses
897856828803741
Research & Development
2,0521,6151,4141,3231,204
Other Operating Expenses
405430120433675
Operating Income
3,6132,6032,3431,6491,199
Interest Expense
-349-305-265-470-341
Other Non-Operating Income (Expense)
121-16-93-38218
Total Non-Operating Income (Expense)
-228-321-358-508-123
Pretax Income
3,3852,2821,9851,1411,076
Provision for Income Taxes
49343639344336
Net Income
2,8981,8531,570642985
Minority Interest in Earnings
-6-8-1--
Net Income Attributable to Preferred Dividends
--235555
Net Income to Common
2,8981,8531,570642985
Net Income Growth
56.39%18.02%144.55%-34.82%-
Shares Outstanding (Basic)
1,4801,4721,4531,4311,431
Shares Outstanding (Diluted)
1,4951,4861,4641,4401,442
Shares Change (YoY)
0.58%1.53%1.65%-0.16%1.79%
EPS (Basic)
1.961.261.080.450.72
EPS (Diluted)
1.941.251.070.450.72
EPS Growth
55.20%16.82%137.78%-37.50%-
Free Cash Flow
3,6582,6451,7929381,316
Free Cash Flow Growth
38.30%47.60%91.05%-28.72%16.25%
Free Cash Flow Per Share
2.451.781.220.650.91
Gross Margin
69.01%68.61%69.49%68.81%68.78%
Operating Margin
18.00%15.54%16.45%13.00%10.09%
Profit Margin
14.41%11.02%11.18%5.50%8.75%
FCF Margin
18.22%15.79%12.58%7.40%11.07%
EBITDA
4,9813,8723,5392,7852,292
EBITDA Margin
24.81%23.12%24.85%21.96%19.28%
EBIT
3,6132,6032,3431,6491,199
EBIT Margin
18.00%15.54%16.45%13.00%10.09%
Effective Tax Rate
14.56%19.11%19.80%38.83%3.35%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.